Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
about
Nonadherence to treatment protocol in published randomised controlled trials: a reviewClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaAssociation of low level viremia with inflammation and mortality in HIV-infected adultsMortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanDesign and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort studyExploring the effect of erythropoietin on mortality using USRDS data.Modeling potential time to event data with competing risks.Selection bias modeling using observed data augmented with imputed record-level probabilities.ANALYSIS OF DEPENDENTLY CENSORED DATA BASED ON QUANTILE REGRESSION.A model-informed rank test for right-censored data with intermediate states.Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.Modeling missingness for time-to-event data: a case study in osteoporosis.Measuring the HIV Care Continuum Using Public Health Surveillance Data in the United States.The Best of Both Worlds: Collaborations Can Improve Epidemiological Analyses of Public Health Data.Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.Sensitivity analyses for informative censoring in survival data: A trial example.Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data.Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models.Early prediction of median survival among a large AIDS surveillance cohort.A score test for association of a longitudinal marker and an event with missing dataThe risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study.Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.Estimating differences in restricted mean lifetime using observational data subject to dependent censoring.Status of adjuvant endocrine therapy for breast cancer.Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.Estimating efficacy in trials with selective crossover.Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.TNF-α Antagonist and Infection in Rheumatoid Arthritis.A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks dataSurvival benefit-based deceased-donor liver allocationA joint test for progression and survival with interval-censored data from a cancer clinical trialLeisure-time physical activity and all-cause mortality in an elderly cohort.Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trialA Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.
P2860
Q26825321-27C9C92B-B5FE-4B06-9FDE-556051B6761DQ28537704-498C564C-1D46-458F-9B51-22092AD8B56AQ28743237-AF04C0B4-6252-49DB-8C3A-075C4617A907Q28749991-1D476E63-F4E6-4403-9A19-BEED0A2F30FDQ30419884-0CDEF2A8-056E-4069-BCC9-8065DBF49AB2Q30620811-53D81314-2D0E-45E1-9E95-2DC445D667C3Q30669557-20DE9738-E03A-450D-852F-BE9A5FB82272Q30846816-E66DD6B7-F7A5-41AF-970A-1F2CDA378754Q30868535-4EA1D4F4-E958-48DD-80D3-6A9571EF5F8AQ30884241-47E6D605-87CF-45B3-99F9-F51D669DA137Q30956395-05ABB714-70D0-46B1-810B-47A04DE0DC19Q30978082-8086F4EA-B17D-4779-9C18-853D1BF00470Q30986216-C401AA05-0B8D-42E0-B093-48C6BE0287B1Q31031235-E7154484-36C9-42FB-A4C3-FAB30BD1C318Q31060225-39FCD9B8-C32C-44FC-B2F6-E67B11CCF2B4Q31062668-BB196A35-E2BE-4889-9EAB-14A586495188Q31109949-64D32FD3-C417-4719-A872-485FD8800671Q31141430-A330B5BD-2749-4944-93EC-3340B50F16ABQ31145127-1AE74A92-55B6-4F9B-9774-9CE9A7C0C7D2Q33289141-AD25E0F3-CDD6-4549-9FC3-00880533B139Q33503383-C599F837-5B8A-415C-B5B9-B87DA4559EC2Q33507274-57642BA9-9EC0-44C3-8950-C312B7B9567BQ33563357-4D0261E5-BE52-4E2C-8879-06C2766B8798Q33567637-6500F3C5-A011-4D27-B8FC-0072E1276F8CQ33609257-82BB27A1-AC7D-4BA8-A0FA-3F55D8626880Q33707284-50EA235A-C925-4ACC-AAED-B84ADB15EDD3Q33721818-261290D9-C8C4-4463-8BC5-FA467AA09BCDQ33735010-CEB9A8FC-AD2F-42A8-8EE7-C70A83FF005EQ33739138-3C22523D-CBB2-43B4-9230-0EA1AEED110DQ33748358-ED46A94A-E8D4-422C-90AA-1187D4ABF532Q33835695-4A665E35-F5A9-4235-A05B-5BC55A381AFAQ33844625-44C18729-79BA-4EDC-8289-F9906A86D578Q33872130-68C71490-52B0-46A0-9C29-C43F15F8A898Q33894150-52A5D43A-C8C0-4401-93D8-397A5503F556Q33956711-829D3FD4-5F6F-4A98-9AFF-8CA91A1FEF5BQ33959131-6FAF7F73-C189-488D-823B-AEBA76301431Q33975335-05C9B2DA-CB42-4509-AC57-1BC6C53C72B4Q33985493-D181DFC9-2C22-41B0-BCD1-5F50DD4705BAQ34041659-5456915C-5CB0-42F4-96A4-9797389A0744Q34060554-B1528FF5-54FD-426D-A385-22E7A81AF2EB
P2860
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Correcting for noncompliance a ...... eighted (IPCW) log-rank tests.
@en
Correcting for noncompliance a ...... bability of censoring weighted
@nl
type
label
Correcting for noncompliance a ...... eighted (IPCW) log-rank tests.
@en
Correcting for noncompliance a ...... bability of censoring weighted
@nl
prefLabel
Correcting for noncompliance a ...... eighted (IPCW) log-rank tests.
@en
Correcting for noncompliance a ...... bability of censoring weighted
@nl
P2860
P1433
P1476
Correcting for noncompliance a ...... eighted (IPCW) log-rank tests.
@en
P2093
Finkelstein DM
P2860
P304
P356
10.1111/J.0006-341X.2000.00779.X
P407
P577
2000-09-01T00:00:00Z